TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02491892 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02235909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00318630 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01682564 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02606019 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02606019 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT02606019 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03713372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05136911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00727636 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02249585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05478226 — Predictive Biomarker (PRD): ADAMTSL4 mRNA
Genes: ADAMTSL4; TSRC1; PP1396; UNQ2803/PRO34012
Study NCT00001190 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00953420 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06506331 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02499783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02284984 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT03131778 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03131778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03131778 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00935363 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study NCT00935363 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02079532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03051659 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04259177 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01763528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01801111 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01801111 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01801111 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01008592 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04912193 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT04289675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03189355 — Predictive Biomarker (PRD): PTPN1 mRNA
Genes: PTPN1; PTP1B
Study NCT01796561 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02358174 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05975892 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02333370 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02333370 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01574170 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study NCT05129215 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT02012920 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT03159195 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03159195 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01015222 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00580021 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00580021 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04033809 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04033809 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04033809 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04033809 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01265368 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01265368 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT00282360 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01987830 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04021069 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00687323 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02914470 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04139447 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00162643 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00270452 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00270452 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03913806 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03913806 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02945215 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02968901 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT02968901 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02968901 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04803370 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02716870 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00769470 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02649465 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00649389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03582332 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04441814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01382940 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05453604 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05453604 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT05453604 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02015598 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00009698 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01165437 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04098536 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02430012 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04165200 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03393130 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03607162 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02899390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00025896 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT02114216 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04089605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00113984 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00113984 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00303784 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03978338 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03978338 — Safety Biomarker (SAF): BDNF
Study NCT00456560 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00456560 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03680794 — Predictive Biomarker (PRD): CD160 mRNA
Genes: CD160; BY55
Study NCT00638469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03011372 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03011372 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00013546 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04819165 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00295698 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00131703 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00148772 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00148772 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00383656 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study NCT02611310 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04564937 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03424863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03447704 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT04076722 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04076722 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT04076722 — Safety Biomarker (SAF): BDNF
Study NCT04352712 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT04352712 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT03450746 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03450746 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02564159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02564159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03728790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01008501 — Predictive Biomarker (PRD): NLRP7 mRNA
Genes: NLRP7; NALP7; NOD12; PYPAF3
Study NCT02882126 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03304548 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03304548 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04466462 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04382716 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT03267758 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03267758 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00496470 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00496470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00496470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03990454 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT04032795 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01680094 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04127877 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03937544 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02547831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study NCT02596334 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02730429 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02941991 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03816657 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02554045 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00305669 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02238028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04101877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04101877 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01513083 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02475915 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02303366 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05754047 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04145557 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04145557 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT04145557 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04510012 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01916720 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT03839979 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00251485 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00207766 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02379741 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01195714 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00697593 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02274584 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03065712 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03284294 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03284294 — Safety Biomarker (SAF): BDNF
Study NCT01968720 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04035642 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00718952 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00718952 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03190577 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00171353 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03909659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05063409 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT02790203 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT00603668 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT01099865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02095964 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02240407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00465153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00465153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04848948 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04848948 — Safety Biomarker (SAF): BDNF
Study NCT03291639 — Predictive Biomarker (PRD): EOMES mRNA
Genes: EOMES; TBR2
Study NCT03045653 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03045653 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04106908 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03762122 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03762122 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02364479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02081339 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02081339 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01701726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00540436 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00540436 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03982407 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00957970 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02414997 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005438 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03323541 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01687998 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT03947320 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02079753 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study NCT00756756 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04401085 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04610723 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04610723 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00932139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01762293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01762293 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01762293 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT00777426 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01884454 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT03980288 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04012983 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT01223300 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06373562 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06373562 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT06373562 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT06373562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06373562 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06373562 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT03166735 — Predictive Biomarker (PRD): AOC3 mRNA
Genes: AOC3; VAP1
Study NCT03166735 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT00076102 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00076102 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03797014 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03208205 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03598283 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03598283 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT03931642 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02608502 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04547738 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02304432 — Predictive Biomarker (PRD): GLDC mRNA
Genes: GLDC; GCSP
Study NCT04453202 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03031054 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02632981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00101595 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00101595 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02299388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02432001 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03280056 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00462436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03473314 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT02658084 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01004783 — Predictive Biomarker (PRD): HMGA2 mRNA
Genes: HMGA2; HMGIC
Study NCT02404155 — Predictive Biomarker (PRD): ACKR1 mRNA
Genes: ACKR1; DARC; FY; GPD
Study NCT02404155 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02902172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02933775 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01153984 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1